Shared Genetic Features of Psoriasis and Myocardial Infarction: Insights From a Weighted Gene Coexpression Network Analysis

被引:0
作者
Zhou, Qiaoyu [2 ]
Shi, Ruizheng [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Med, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Dept Cardiovasc Med, Xiangya Hosp 3, Changsha, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2024年 / 13卷 / 07期
基金
芬兰科学院; 中国国家自然科学基金;
关键词
ceRNA; differential gene analysis; myocardial infarction; psoriasis; WGCNA; TYROSINE KINASE 2; INHIBITION; RISK; ASSOCIATION; MORTALITY; TRANSPORT; STROKE; FAMILY; COHORT; FLVCR2;
D O I
10.1161/JAHA.123.033893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Increasing evidence suggests a higher propensity for acute myocardial infarction (MI) in patients with psoriasis. However, the shared mechanisms underlying this comorbidity in these patients remain unclear. This study aimed to explore the shared genetic features of psoriasis and MI and to identify potential biomarkers indicating their coexistence.Methods and Results Data sets obtained from the gene expression omnibus were examined using a weighted gene coexpression network analysis approach. Hub genes were identified using coexpression modules and validated in other data sets and through in vitro cellular experiments. Bioinformatics tools, including the Human microRNA Disease Database, StarBase, and miRNet databases, were used to construct a ceRNA network and predict potential regulatory mechanisms. By applying weighted gene coexpression network analysis, we identified 2 distinct modules that were significant for both MI and psoriasis. Inflammatory and immune pathways were highlighted by gene ontology enrichment analysis of the overlapping genes. Three pivotal genes-Src homology and collagen 1, disruptor of telomeric silencing 1-like, and feline leukemia virus subgroup C cellular receptor family member 2-were identified as potential biomarkers. We constructed a ceRNA network that suggested the upstream regulatory roles of these genes in the coexistence of psoriasis and MI.Conclusions As potential therapeutic targets, Src homology and collagen 1, feline leukemia virus subgroup C cellular receptor family member 2, and disruptor of telomeric silencing 1-like provide novel insights into the shared genetic features between psoriasis and MI. This study paves the way for future studies focusing on the prevention of MI in patients with psoriasis.
引用
收藏
页数:12
相关论文
共 57 条
  • [1] The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study
    Abuabara, K.
    Lee, H.
    Kimball, A. B.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (05) : 1066 - 1073
  • [2] Transcriptomics Signature from Next-Generation Sequencing Data Reveals New Transcriptomic Biomarkers Related to Prostate Cancer
    Alkhateeb, Abedalrhman
    Rezaeian, Iman
    Singireddy, Siva
    Cavallo-Medved, Dora
    Porter, Lisa A.
    Rueda, Luis
    [J]. CANCER INFORMATICS, 2019, 18
  • [3] Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies
    Armstrong, Ehrin J.
    Harskamp, Caitlin T.
    Armstrong, April W.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (02): : e000062
  • [4] Toll-like receptor 9 signaling after myocardial infarction: Role of p66ShcA adaptor protein
    Baysa, Anton
    Maghazachi, Azzam A.
    Sand, Kristin Larsen
    Campesan, Marika
    Zaglia, Tania
    Mongillo, Marco
    Giorgio, Marco
    Di Lisa, Fabio
    Gullestad, Lars
    Mariero, Lars H.
    Vaage, Jarle
    Valen, Guro
    Stenslokken, Kare-Olav
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 644 : 70 - 78
  • [5] The p66ShcA adaptor protein regulates healing after myocardial infarction
    Baysa, Anton
    Sagave, Julia
    Carpi, Andrea
    Zaglia, Tania
    Campesan, Marika
    Dahl, Christen P.
    Bilbija, Dusan
    Troitskaya, Maria
    Gullestad, Lars
    Giorgio, Marco
    Mongillo, Marco
    Di Lisa, Fabio
    Vaage, Jarle I.
    Valen, Guro
    [J]. BASIC RESEARCH IN CARDIOLOGY, 2015, 110 (02)
  • [6] Psoriasis
    Boehncke, Wolf-Henning
    Schoen, Michael P.
    [J]. LANCET, 2015, 386 (9997) : 983 - 994
  • [7] Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis
    Brauchli, Y. B.
    Jick, S. S.
    Miret, M.
    Meier, C. R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (05) : 1048 - 1056
  • [8] Molecular and clinical effects of selective tyrosine kinase 2 inhibition with deucravacitinib in psoriasis
    Catlett, Ian M.
    Hu, Yanhua
    Gao, Lu
    Banerjee, Subhashis
    Gordon, Kenneth
    Krueger, James G.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (06) : 2010 - +
  • [9] Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy
    Chamcheu, Jean Christopher
    Roy, Tithi
    Uddin, Mohammad Burhan
    Banang-Mbeumi, Sergette
    Chamcheu, Roxane-Cherille N.
    Walker, Anthony L.
    Liu, Yong-Yu
    Huang, Shile
    [J]. CELLS, 2019, 8 (08)
  • [10] Methyltransferase Dot1l preferentially promotes innate IL-6 and IFN-β production by mediating H3K79me2/3 methylation in macrophages
    Chen, Xiang
    Liu, Xingguang
    Zhang, Yunkai
    Huai, Wanwan
    Zhou, Qingqing
    Xu, Sheng
    Chen, Xi
    Li, Nan
    Cao, Xuetao
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (01) : 76 - 84